Sciex to resell RedShiftBio's new technology

By The Science Advisory Board staff writers

November 17, 2021 -- Sciex has inked a deal to resell the AQSPro from RedShift Bioanalytics throughout the U.S., providing more biopharmaceutical labs with access to critical data.

The technology integrates automated sample handling for 24- and 96- well plate formats and offers a unique microfluidic system and a quantum cascade laser-based optical system. Real-time background subtraction eliminates the need to dialyze samples, and the AQSPro can measure a range of native sample concentrations from less than 0.1mg/ml to greater than 200 mg/ml.

Sciex launches BioPhase 8800 for high-throughput capillary electrophoresis
Sciex has launched BioPhase 8800, a new capillary electrophoresis system for enhanced biologic characterization in the development of biopharmaceutical...
Sciex, Genedata to develop new enterprise MS software
Sciex and Genedata have formed a strategic partnership to develop new software solutions for biopharmaceutical mass spectrometry (MS) applications.
Sciex, Waters collaborate to offer fully integrated LC-MS systems
Sciex and Waters have inked a deal to provide integrated liquid chromatography and mass spectrometry (LC-MC) systems.
Sciex appoints new president
Sciex has appointed Joe Fox as president effective April 1, taking over for Inese Lowenstein.
Seer, Sciex to provide end-to-end proteomics solutions
Sciex and Seer have inked a nonexclusive commercial agreement. Under the deal, Seer will market Sciex's mass spectrometry systems together with its Proteograph...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter